ORDENTLICH PETER (Chief Scientific Officer) sold 99.0% of their position (25K shares) of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market sale worth $626.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+3.77K
Price / share
$6.35
Trade value
$23.95K
% of position
Common Stock
Shares
−3.77K
Price / share
$25.01
Trade value
$94.34K
% of position
Common Stock
Shares
+4.03K
Price / share
$6.38
Trade value
$25.70K
% of position
Common Stock
Shares
−4.03K
Price / share
$25.01
Trade value
$100.75K
% of position
Common Stock
Shares
+17.20K
Price / share
$6.38
Trade value
$109.74K
% of position
Common Stock
Shares
−17.20K
Price / share
$25.05
Trade value
$430.94K
% of position
Net shares
+0.00
Net value
-$466.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2022 | M · Option Exercise | +3.77K | $6.35 | $23.95K | 1423.4% | 265.00 | 4.04K |
| Common Stock Direct | 12/1/2022 | S · Sale | −3.77K | $25.01 | $94.34K | 93.4% | 4.04K | 265.00 |
| Common Stock Direct | 12/1/2022 | M · Option Exercise | +4.03K | $6.38 | $25.70K | 1520.0% | 265.00 | 4.29K |
| Common Stock Direct | 12/1/2022 | S · Sale | −4.03K | $25.01 | $100.75K | 93.8% | 4.29K | 265.00 |
| Common Stock Direct | 12/2/2022 | M · Option Exercise | +17.20K | $6.38 | $109.74K | 6490.6% | 265.00 | 17.46K |
| Common Stock Direct | 12/2/2022 | S · Sale | −17.20K | $25.05 | $430.94K | 98.5% | 17.46K | 265.00 |
| Total | +0.00 | -$466.64K | ||||||
Stock Options (Right to buy)
Common Stock
4.03K shares
Shares
−4.03K
Strike price
6.38
Held after
0.00
Exercisable
—
Stock Options (Right to buy)
Common Stock
3.77K shares
Shares
−3.77K
Strike price
6.35
Held after
0.00
Exercisable
—
Stock Options (Right to buy)
Common Stock
17.20K shares
Shares
−17.20K
Strike price
6.38
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy) Direct | Common Stock4.03K shares | 12/1/2022 | M · Option Exercise | −4.03K | 6.38 | — | 0.00 |
| Stock Options (Right to buy) Direct | Common Stock3.77K shares | 12/1/2022 | M · Option Exercise | −3.77K | 6.35 | — | 0.00 |
| Stock Options (Right to buy) Direct | Common Stock17.20K shares | 12/2/2022 | M · Option Exercise | −17.20K | 6.38 | — | 0.00 |